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Abstract
Introduction: Regenerative peripheral nerve interfaces (RPNIs) are biological constructs which amplify neural signals
and have shown long-term stability in rat models. Real-time control of a neuroprosthesis in rat models has not yet
been demonstrated. The purpose of this study was to: a) design and validate a system for translating electromyography
(EMG) signals from an RPNI in a rat model into real-time control of a neuroprosthetic hand, and; b) use the system to
demonstrate RPNI proportional neuroprosthesis control.
Methods: Animals were randomly assigned to three experimental groups: (1) Control; (2) Denervated, and; (3) RPNI. In
the RPNI group, the extensor digitorum longus (EDL) muscle was dissected free, denervated, transferred to the lateral
thigh and neurotized with the residual end of the transected common peroneal nerve. Rats received tactile
stimuli to the hind-limb via monofilaments, and electrodes were used to record EMG. Signals were filtered,
rectified and integrated using a moving sample window. Processed EMG signals (iEMG) from RPNIs were
validated against Control and Denervated group outputs.
Results: Voluntary reflexive rat movements produced signaling that activated the prosthesis in both the
Control and RPNI groups, but produced no activation in the Denervated group. Signal-to-Noise ratio between
hind-limb movement and resting iEMG was 3.55 for Controls and 3.81 for RPNIs. Both Control and RPNI
groups exhibited a logarithmic iEMG increase with increased monofilament pressure, allowing graded
prosthetic hand speed control (R2 = 0.758 and R2 = 0.802, respectively).
Conclusion: EMG signals were successfully acquired from RPNIs and translated into real-time neuroprosthetic
control. Signal contamination from muscles adjacent to the RPNI was minimal. RPNI constructs provided
reliable proportional prosthetic hand control.
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Introduction
Approximately 185,000 individuals suffer limb loss an-
nually in the United States [1]. The growing rate of
amputees and technological advancements have greatly
improved human-neuroprosthetic interfacing [2]. A
comprehensive literature review on the needs and pri-
orities of prostheses users performed by Cordella et al.
in 2016 revealed that an estimated 75% of upper pros-
thetic users wore functional prostheses for at least 8 h
per day, compared with only 45% of cosmetic pros-
thesis owners [3]. A functional prosthesis was more
likely to be worn the higher the level of amputation,
and especially during dynamic activities of daily living,
such as work, driving and sports [3]. Importantly,
upper arm amputees who tested both conventional
(body powered or myoelectric arms) and the DEKA
Gen 3 advanced myoelectric prosthesis found conven-
tional prostheses performed faster, and with smoother
motions and less movement deviation than the ad-
vanced DEKA prosthetic device [4]. This finding is
largely attributed to a lack of an intuitive, functional
neural interface that can provide high fidelity control
signals to actualize the functionality of advanced neu-
roprosthetic devices.
Advanced anthropomorphic modular prosthetic arm
systems have only become commercially available in
the last 5 years, in large part due to technology devel-
oped with DARPA’s funding of the Revolutionizing
Prosthetics Program in 2006 [5]. Currently, multi-elec-
trode-based prosthetic devices, such as the DEKA arm
(DEKA, Manchester, NH), i-Limb (TouchBionics,
Touch Bionics, Mansfield, MA), the Johns Hopkins
Modular Prosthetic Limb (MPL, Johns Hopkins University
Applied Physics Lab, Baltimore, MD), and Ottobock (Otto
Bock HealthCare, Duderstadt, Germany), provide in-
creased ranges of motion, dexterity and control options,
and are capable of up to five-finger movements and 20 de-
grees of freedom [6, 7]. However, a limitation in control-
ling these advanced robotic prostheses is the need for an
appropriate neural interface that can extract clear multi-
functional signal information at a speed that matches nat-
uralistic human motion [8, 9].
Neural interfaces, i.e. the use of electrodes to record
physiological signals for voluntary prosthetic control,
come in different forms and all have unique advantages
and challenges. All prostheses require either nerve or
muscle electrodes as part of the neural interface [6],
and consequently, interfacing electrodes vary in size
(standard pad to microelectrodes), shape (multipolar
cuff, fine wire, sieve), number of electrode sites (bipo-
lar or multi-array), and location (transverse intrafasci-
cular multichannel nerve, longitudinal intrafascicular
nerve, epimysial, intramysial and intracortical micro-
electrode arrays placed in the cortex) [9–12]. Cuff
electrodes circumferentially envelope peripheral nerves
and nerve fascicles, and have shown promising results
in signal transduction; however, long term signal
fidelity may be compromised due to epineurial inflam-
mation and scarring [13–15]. Both intrafascicular elec-
trodes and sieve electrodes allow for nerve and signal
specificity, but are hampered by long-term signal loss
due to biofouling [16–18]. Epimysial and intramysial
electrodes can be larger in size, are physically more ro-
bust, are less compromised by fibrosis, and transduce
myoelectric signals with less impedance [19].
The most successful form of neural interfacing to
date is Targeted Muscle Reinnervation (TMR) [20].
TMR is an FDA-approved procedure to surgically con-
struct additional EMG control sites using residual
nerves [21]. Remaining nerves from the amputated
limb are transferred to expendable regions of residual
muscle in or near the residual limb; commonly, the ip-
silateral pectoral muscle is denervated and used for
this purpose. The nerves reinnervate the “target” and
produce additional EMG signal sites for prosthetic
control. Ideally, TMR is performed during the initial
amputation procedure, which has been proven to re-
duce neuroma formation [22–24]. TMR uses external
skin surface electrodes to transduce EMG signals, thus
avoiding the build-up of connective tissue on elec-
trodes due to a foreign body reaction. Yet a disadvan-
tage of surface EMG electrode systems is their lack of
robustness to variance caused by donning, fatigue, per-
spiration, and other conditions that cause positional
and physiological changes in the electrical characteris-
tics of the signal sites [21]. Moreover, the reinnervation
of the whole pectoral muscle with up to three nerves,
each of which is responsible for specific and distinct
functions in the arm, requires the implementation of
complex pattern classification and feature extraction
algorithms, such that the overlapping neural signals ac-
quired from the EMG electrode array can be decoded
and assigned to their intended control targets [25].
Despite the advancements that have benefitted
human-prosthetic interfacing, a need remains for a
neural interface that can provide real-time, long-term,
contamination free, signal fidelity for optimal pros-
thetic activation and control. In this study, we use the
Regenerative Peripheral Nerve Interface (RPNI) as a
strategy for neural interfacing. RPNIs are neuromuscu-
lar biological interfaces surgically constructed from
free muscle grafts (3 × 1 cm.) obtained from expend-
able skeletal muscle in the residual limb or from a dis-
tant site. The residual peripheral nerves are dissected
into single nerve fascicles, or groups of fascicles, to
create functional units. The muscle grafts are then
neurotized by the terminal branches of the residual
nerves. Revascularization, regeneration, and eventually
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reinnervation allows the RPNI to mature in 3 to
4 months [26, 27]. This technique reduces the amount
of neural manipulation and risk of iatrogenic nerve
damage. Previous studies in our laboratory have shown
that RPNIs transduce evoked muscle potentials for up
to 18 months, prevent neuroma formation, and amplify
motor nerve signaling [28, 29]. Thus, RPNI technology
takes advantage of the signal from individual muscles
that can be recorded via intramuscular EMG signals
generated from the RPNI, obviating the need for signal
decoding of multi-nerve motor features via classifica-
tion algorithms [21].
There have been few investigations into the fine
motor control of neuroprosthetic devices using the
RPNI technique. As such, the purposes of this study
were to: a) build and validate an algorithm for translat-
ing EMG signals from RPNIs for real-time control of a
myoelectrically actuated neuroprosthetic hand; and b)
use this algorithm to demonstrate the ability of RPNIs
to provide proportional neuroprosthesis control. It was
hypothesized that both Control and RPNI groups
would demonstrate reliable and proportional control
of the myoelectric hand, while the Denervated group
would not activate the neuroprosthesis.
Methods
Animal model
All procedures were approved by the University of Mich-
igan, Institutional Animal Care and Use Committee, and
were in strict accordance with the National Research
Council’s Guide for the Care and Use of Laboratory Ani-
mals (1996) [30]. Retired F344 male breeder rats (Charles
River, Wilmington, MA) weighing 300 to 420 g were anes-
thetized with weight-based Pentobarbital and adminis-
tered Buprenorphine-HCl as analgesia.
Regenerative peripheral nerve Interface surgery
The study design consisted of three separate groups,
Control (n = 2), Denervated (n = 1), and RPNI (n = 3).
In each group, all rats underwent a proximal and distal
tenotomy of the extensor digitorum longus (EDL)
muscle. In the Control group, no additional interven-
tions were performed. In the Denervated and RPNI
groups, the common peroneal nerve was divided and
the free EDL muscle graft was transferred to the lateral
thigh. In the RPNI group, the proximal end of the di-
vided peroneal nerve was implanted into the EDL skel-
etal muscle graft to create an RPNI. In the Denervated
group, the proximal end of the peroneal nerve was
reflected proximally to prevent EDL skeletal muscle
graft reinnervation (Fig. 1).
Two stainless steel electrodes made of Cooner wire
(Cooner Wire Co., Chatsworth, CA) were sutured onto
the EDL epimysium, with electrodes separated longitu-
dinally by 1.5 cm. The EDL muscle was then covered
by a single-layer of acellular porcine intestinal sub-
mucosa scaffold (SIS) (Surgisis, Cook Biotech, West
Lafayette, IN). The leading ends and connecting cables
of the electrodes were tunneled, coiled, and buried
subcutaneously within the dorsum of each rat between
the scapulae.
Testing protocol
Five months following implantation, the free ends of
the implanted electrode cables were exposed through a
dorsal incision. EMG signals were then recorded, amp-
lified to 1000x and band-pass filtered (1–500 Hz) on a
custom-built analog bipolar instrumentation amplifier.
Signal amplitudes were calibrated using a function
generator (B&K Precision, Model 4075, B&K Precision
Corporation, Yorba Linda, CA) and oscilloscope
Fig. 1 Left: Control group with primary repair of the extensor digitorum longus muscle (EDL) tenotomies without denervation of the muscle.
Center: Denervated group with free EDL muscle graft performed to the lateral thigh. Neurotization and reinnervation was not performed, leaving
the EDL muscle graft without innervation. Electrode placement was identical to the Control group. Right: Regenerative Peripheral Nerve Interface
(RPNI) group with free EDL muscle graft performed to the lateral thigh. Neurotization and reinnervation were implemented using the peroneal
nerve. Each rat received bipolar epimysial electrodes (white), whose wires (blue) were tunneled subcutaneously to the upper dorsum. a. bipolar
electrode cables. b. tibialis anterior muscle; c. soleus and gastrocnemius muscles; d. distal end of common peroneal nerve; e. EDL muscle; f.
proximal common peroneal nerve; g. tibial nerve
Frost et al. Journal of NeuroEngineering and Rehabilitation          (2018) 15:108 Page 3 of 9
(Agilent InfiniiVision Model MSO-X 2012-A, Agilent
Technologies, Santa Clara, CA). The amplified and fil-
tered signals were acquired at a 3 kHz sampling rate
using a data acquisition card (NI BNC 2120, National
Instruments, Austin, TX) using LabVIEW software
(National Instruments, Austin, TX). During post
processing, the signals were digitally rectified and
zero-phase low-pass filtered to 50 Hz.
A von Frey monofilament testing protocol was initi-
ated to evoke reflex anterior compartment dorsi-
flexion of the hind paw, and activation of the EDL or
RPNI muscle [31]. During testing, each rat was placed
in a 4 × 5 × 8 in.3 Plexiglas® box with a wire mesh bot-
tom. Monofilament fibers were applied to the left ex-
perimental ankle to induce a voluntary muscle reflex
leg movement. Monofilament pressure was initiated at
4 g of force, and monofilament fibers of up to 100 g
were randomly administered to the ankle. Four cycles
lasting five minutes were performed at each monofila-
ment force level. All rats were free to ambulate while
connected to the myoelectric prosthesis to correct for
the possibility of EMG signaling from other muscles.
To avoid habituation, 1–2 min of rest was allowed be-
tween each testing cycle. Rats in each group were eval-
uated for 3 days with 2 days of rest between each
evaluation period. The monofilament testing lasted no
longer than 2 h per day. Post-evaluation, all rats were
sacrificed and their hind limb dissected in order to as-
sess the amount of scar tissue and vascularity in the
repaired EDL (Control group) and free grafted muscles
in the lateral thigh (RPNI and Denervated groups).
Prosthetic activation and hind limb movement were
video recorded at 120 frames per second using a
high-speed, high-definition camera (GoPro Hero2, San
Mateo, CA). Rectified EMG and prosthetic activation
were synchronized and recorded using the LabVIEW
software (Fig. 2).
Algorithm design
A computer algorithm was written using LabVIEW to
allow interpretation of the EMG activity and prosthetic
control. The rectified and filtered EMG signals were
divided into 300 millisecond intervals. Each 300 milli-
second interval was then integrated with respect to
time and a mean value iEMG was calculated in units
of mV × sec. A running threshold was calculated by
averaging all previous intervals, giving 50% weight to
the immediately prior interval. Activation of the pros-
thesis occurred when the real-time iEMG was greater
than the running threshold by at least one standard de-
viation (Fig. 3).
Graded control of the prosthesis was achieved by
modulation of the output voltage to the “DMC +
Hand” (Otto Bock Healthcare, Vienna, Austria) using
an Arduino Uno R3 prototyping board (Arduino LLC.
Cambridge, MA) equipped with a motor-driving ampli-
fier (SparkFun Electronics, Niwot, CO). Output voltage
to the hand was increased with larger iEMG values by
calculating the number of standard deviations above
the running threshold for each iEMG interval (Eq. 1).
VOutput ¼ VMax− VMax1þ SDAbove Thresholdð Þ ð1Þ
Data analysis
Video recordings of each testing period were analyzed
to determine interface performance. Sensitivity and
specificity were each calculated based on appropriate
activation of the prosthesis during hind limb move-
ment and non-activation during periods of rest,
respectively. The number of recorded prosthetic move-
ments during each 4-min testing period was compared
to the total number of observed leg movements to de-
termine sensitivity (Eq. 2). The number of errant
Fig. 2 EMG signals integrated over 300 msec (iEMG) – based
prosthesis activation during one testing session. Plots of filtered EMG
tracings (Blue) and periods of prosthesis activation (Green) during 40 s
of testing in Control (Top), Denervated (Middle) and RPNI (Bottom)
groups. Baseline iEMG is calculated as a running average. An algorithm
activates the prosthesis after detecting an iEMG window more than 1
standard deviation above the mean iEMG
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activations of the prosthesis during rest intervals with
no hind limb movement was calculated to determine
specificity (Eq. 3). Within group Student’s T-Test stat-
istical computations were performed using SPSS Statis-
tics 22, (SPSS, IBM Inc., 2013, Armonk, NY).
Significance levels were set to α = 0.05.
Sensitivity ¼ Prosthetic activations after hindlimb movement
Total number of hindlimb movements
ð2Þ




Accuracy of Neuroprosthesis activation
In total, 1040 Control group hind limb movements in
208 min and 876 RPNI group hind limb movements in
172 min were captured. (see Video, Additional file 1: Video
S1, which demonstrates prosthesis activation in response to
monofilament stimulation on the volar side of the hind paw)
Significantly reduced hind paw movements were recorded
during 51 min within the Denervated group, likely resulting
from the lack of peroneal nerve innervation to the lateral
compartment musculature of the lower hind limb (see Video,
Additional file 2: Video S2, which demonstrates no prosthesis
activation in response to monofilament stimulation on the
volar side of the hind paw in a Denervated rat).
The iEMG activation signals were significantly higher in
both the Control and RPNI groups when compared to the
baseline signals obtained during the between-trial resting
periods, indicating that the calculated threshold denoting
prosthesis activation (Eq. 1) was successfully defined. The
calculated sensitivity (ability to detect prosthetic activation
after stimulation) and specificity (ability to prevent un-
wanted activation during rest) values for prosthesis activa-
tion are reported in Table 1. Signal to noise ratio means
and standard deviations between iEMG resulting in initial
hind limb movement, (i.e. iEMG acquired during the low-
est monofilament stimulus resulting in paw retraction,
and therefore prosthesis activation) and resting iEMG was
3.55 ± 0.38 and 3.81 ± 0.52 for the Control and RPNI
groups, respectively.
Fig. 3 Schematic showing acquisition, transduction and analysis of real-time recorded EMG signaling from an RPNI rat. a. Bipolar collection of raw
EMG signals. Ground electrode is referenced in ear. b. Raw EMG signals undergo signal processing in the form of filtering and rectification. c. & d.
300 msec consecutive EMG signal acquisition intervals obtained during c. no observed leg motion (baseline signal activity below threshold), and
d. Leg motion and subsequent prosthetic hand activation due to signal surpassing threshold of activation. Blue lines: EMG signal; Red lines: iEMG
value; Green lines: Activation threshold





(n = 2 rats)
Denervated
(n = 1 rat)
RPNI
(n = 3 rats)
Mass (g) on test day 420 397 302
Sensitivity 0.902 (0.06) a 0.879 (0.08)
Specificity 0.998 (0.004) 1.0 (0.0) 0.988 (0.02)
Values are means (± 1 SD). Sensitivity and specificity were excellent across all
three groups. a Denervated group as expected did not show activity during rat
movement; therefore no sensitivity was calculated
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Proportional control of the Neuroprosthesis
Proportional control of a neuroprosthesis requires the
ability to distinguish variations in EMG peak record-
ings from volitional behavior. Using this tenet, EMG
amplitude was mapped 1:1 to the speed of prosthetic
hand movement [32]. Increasing von Frey monofila-
ment pressure led to an observable increase in rat hind
limb movement intensity. Rats in the Control and
RPNI groups had a positive logarithmic correlation be-
tween von Frey filament forces (intensity of stimulus),
EMG amplitude, and therefore the instantaneous volt-
age used to actuate the prosthetic hand. This positive
correlation enabled a pre-programmed, graded control
of the prosthetic hand speed (R2 = 0.802, p < 0.05 and
R2 = 0.758, p < 0.05, respectively) (Fig. 4).
As expected, no significant correlations were found
between resting “baseline” iEMG activity and the
monofilament pressure subsequently used for either
the Control or RPNI groups (R2 = 0.12 and R2 = 0.19,
respectively). This is expected, as changes in “baseline”
iEMG activity results from biologic and electronic
variation, whereas increased iEMG activity during acti-
vation is due to increased muscle activation, contrac-
tion, and movement, not random variation (Fig. 5).
Discussion
Regenerative peripheral nerve interfaces (RPNI) pro-
vide a biologic connection to peripheral nerves to
amplify efferent motor action potentials producing
high-fidelity motor control signals and favorable signal
to noise ratios. In this study, we have demonstrated re-
liable RPNI signal transduction in real-time EMG sig-
nals obtained during voluntary muscle activation. To
date, this is the first study to demonstrate both real
time and proportional control of a myoelectric pros-
thesis using an RPNI.
The amplitude based direct control algorithm strat-
egy determined for this study was modelled using sim-
ple linear regression. While there are many means of
quantifying muscle activity using myoelectric signals
[33], integrated EMG was chosen as the proportional
input to the controller, as it has been shown to be a re-
liable quantifier of muscle force [34]. In order to reset
the integration to zero, a 300 millisecond acquisition
window was employed; the window timespan was
chosen to ensure that at maximum opening velocity
(300 mm/s), the prosthetic hand does not exceed its
opening width (100 mm) [35]. To ensure that the pros-
thetic gripper’s activation does not occur as a result of
background noise or previous myoelectric activity, a
running threshold was computed using a weighted
average of the myoelectric signals recorded during pre-
vious acquisition windows. Consequently, the pros-
thetic hand was actuated only if the integrated EMG
signal obtained during the current sampling window
was one standard deviation above threshold [25];
Fig. 4 A semi-logarithmic relationship between monofilament pressure applied and iEMG recorded during four testing blocks. Each block lasted
5 min for each increment of pressure increase in RPNI and Control groups (blue and orange, respectively). Monofilament pressure is graphed
logarithmically to linearize each graph. Each represents the mean ± 1 SD for the average of 54 leg movements for control and 51 leg movements
for RPNI per increment of pressure. Positive trends in both RPNI and Control groups imply RPNI transduced EMG signals of proportional intensity
similar to that of an in situ Control
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during actuation, the gripper’s velocity was propor-
tional to the amount of discrete standard deviations
that iEMG lay above threshold.
An important criterion in patient satisfaction resides
in the reaction time of the prosthetic device [24, 36–38].
The algorithm in this study integrated EMG signals over
300 millisecond intervals, building an acceptable 300
millisecond delay into the prosthesis activation time. In-
tegrating EMG signals over this period reduced errant
prosthetic activation due to random variation in baseline
EMG. Future studies utilizing RPNI interfaces with alter-
native methods for prosthesis activation can reduce this
built-in delay. In the present study, prosthetic hand
speed was increased with increasing amplitude of iEMG
signals. A strong, positive correlation existed between
iEMG signal amplitude and the monofilament force ap-
plied to the rat’s limb (i.e. the experimental stimulus).
This is pivotal, as adjusting both speed and directional
movement of a prosthetic device restores greater func-
tionality to the amputee.
One of the primary challenges in neural interfaces is
long-term durability in performance. The current
study shows that RPNIs were safe and effective in the
rat hind limb. As expected, post-experimental gross
evaluation of the lateral thigh compartment revealed
that the free muscle grafts were healthy in RPNI group
rats, but were severely atrophic in the Denervated
group. Furthermore, the consistently low EMG signals
derived from the Denervated group signify that RPNI
EMG activity is not affected by motion artifact or
crosstalk from neighboring muscles.
The implantation procedures were well tolerated,
consistent with previous RPNI implantation surgeries
[27–29, 39]. Within the lifespan of the rat, we have ob-
served minimal to no signal degradation over at least
7 months post implantation [29]. The electrodes im-
planted in the RPNI in this study were stainless steel,
and interfaced directly with transferred skeletal
muscle, thereby avoiding direct contact with the per-
ipheral nerve and corresponding biofouling of the elec-
trode, possible neural inflammation and injury. While
muscle tissue tolerates the presence of epi- or intra--
muscular electrodes fairly well, electrode materials and de-
signs are currently being investigated to continue to
minimize the inflammatory response. [40, 41]
The study’s purposes included proof that signals
transduced from only one RPNI are suitable to control
a one degree of freedom (DOF) myoelectric hand.
RPNI technology with multiple implanted RPNIs
would also be applicable for prostheses capable of
many DOFs. As devised, each RPNI is anatomically
“hard-wired” from select motor control areas of the
brain through peripheral nerves to individual RPNIs.
Consequently, multiple RPNI EMG signals, or
co-activation, could be decoded using linear regression
control or parallel multi-site control as accomplished
Fig. 5 Mean ± 1 Standard Deviation of iEMG values obtained during baseline (blue) and activation trials regardless of monofilament pressure
(orange) in Control, Denervated and RPNI rat cohorts. iEMG is calculated as the area under the curve measured during consecutive 300 msec
intervals of EMG signal acquisition during testing. Activated iEMG is recorded during rat movement while baseline iEMG is obtained during rest. †
Denervated group as expected did not show activity during rat movement; therefore, no activated iEMG was calculated. A * indicates significantly
higher activation signals, when compared with relative baseline signals within Control and RPNI groups (p < 0.05)
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with signals available in TMR [42]. Control strategies
such as amplitude based direct control, as well as se-
quential and simultaneous pattern recognition have
been studied with able bodied and TMR patients [32].
Those who study efficient control may find that pro-
viding several strategies may allow a neuroprosthesis
user to achieve fine actuation with direct control, and
larger movements with simultaneous control [42].
There are inherent limitations to demonstrating the
feasibility of myoelectric prosthesis control using a rat
model. Limiting RPNI implantation to one RPNI per
one rat hind limb allows for only a simple model which
limits prosthetic functionality to single axis actuation.
RPNIs are currently being implanted in humans, on
multiple individual nerve branches, to provide numer-
ous independent DOF. In this manner, each RPNI will
contribute to several movements of a prosthesis when
the transduced EMG signals are processed using pat-
tern recognition.
Finally, in this study, we valuated outcomes 135 days
after RPNI surgery with electrode implantation. This
time-point was selected based on previous studies
showing RPNI revascularization, muscle fiber regener-
ation, and reinnervation occurring at 120 days [29].
Future longitudinal studies of RPNI control of a neuro-
prosthetic device are currently assessing the lifetime
efficacy of RPNI signal transduction.
Conclusion
This study validated an algorithm for translating EMG sig-
nals from RPNIs for real-time control of a neuroprosthetic
hand. Signal contamination from muscles adjacent to the
RPNI was minimal. The EMG signals were successfully
acquired from RPNIs and translated into real-time neuro-
prosthetic control via an algorithm that allowed for
concrete demonstration that RPNIs provide reliable pro-
portional control of the neuroprosthesis. RPNI myoelec-
tric hand control was both sensitive and specific.
Additional files
Additional file 1: Video S1. Which illustrates prosthetic hand activation
using RPNI generated myoelectric signals, in response to monofilament
application to the left hind paw of a rat fitted with an RPNI. (MP4 12600 kb)
Additional file 2: Video S2. Which illustrates a denervated rat experimental
trial, in which monofilament application fails to produce actuation of the
prosthetic hand. (MP4 4092 kb)
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